Methylphenidate prolongs symptom-free period of experimental prion disease in mice.
Department of Microbiology and Molecular Genetics, IMRIC, the Hebrew University Faculty of Medicine, POB 12221, Jerusalem 91120, Israel.
Israel
I
Nissan
Department of Microbiology and Molecular Genetics, IMRIC, the Hebrew University Faculty of Medicine, POB 12221, Jerusalem 91120, Israel.
Inbar
I
Gahali-Sass
Department of Microbiology and Molecular Genetics, IMRIC, the Hebrew University Faculty of Medicine, POB 12221, Jerusalem 91120, Israel.
Alexander
A
Rouvinski
Department of Microbiology and Molecular Genetics, IMRIC, the Hebrew University Faculty of Medicine, POB 12221, Jerusalem 91120, Israel.
Kirill
K
Makedonski
Department of Microbiology and Molecular Genetics, IMRIC, the Hebrew University Faculty of Medicine, POB 12221, Jerusalem 91120, Israel.
Albert
A
Taraboulos
Department of Microbiology and Molecular Genetics, IMRIC, the Hebrew University Faculty of Medicine, POB 12221, Jerusalem 91120, Israel; Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah-Hebrew University Medical Center, Ein Kerem POB 12000, Jerusalem 91120, Israel. Electronic address: yuvalt@hadassah.org.il.
Yuval
Y
Tal
D000818:Animals; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D017096:Prion Diseases / Q000188:drug therapy*
D000697:Central Nervous System Stimulants; D008774:Methylphenidate
Methylphenidate; Prions; Scrapie